In March 2025, the company declared new programs for just a direct-to-client presenting of its Wegovy weight loss drug. The company recognized a new pharmacy, named NovoCare, which would cost buyers $499 per 30 days for usage of the drug, below half the cost of the drug through other pharmaceutical distribution networks.[fifty three]But Rybelsus an